Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 16Terminated 2Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 30Myelodysplastic Syndromes 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia 17Multiple Myeloma 13Lymphoma, Non-Hodgkin 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12Leukemia, Lymphocytic, Chronic, B-Cell 12Lymphoma 11Hodgkin Disease 11Myeloproliferative Disorders 9Congenital Abnormalities 9Neoplasms, Plasma Cell 8Leukemia, Myeloid, Accelerated Phase 8Blast Crisis 8Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Myeloid, Chronic-Phase 7Primary Myelofibrosis 6Myelodysplastic-Myeloproliferative Diseases 6Lymphoma, Mantle-Cell 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Juvenile 6Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5Hematologic Neoplasms 5Graft vs Host Disease 5Burkitt Lymphoma 5Sezary Syndrome 4

Interventions

fludarabine phosphate 5Cyclophosphamide 4Whole-Body Irradiation 3Cyclosporine 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3fludarabine 2Stem Cell Transplantation 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Methylprednisolone 2Hydroxyurea 2Busulfan 2Antilymphocyte Serum 2ruxolitinib 1nelarabine 1fresolimumab 1arsenous acid 1Watchful Waiting 1Thiotepa 1Tetradecanoylphorbol Acetate 1Surveys and Questionnaires 1RG7388 1Phlebotomy 1Oxycodone 1Observation 1Nivolumab 1N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1Mycophenolic Acid 1Moxifloxacin 1Morphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Polycythemia Vera × Busulfan × Clear all
NCT02410551 2018-10-30

Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)

M.D. Anderson Cancer Center

Phase 2 Terminated
4 enrolled 5 charts
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT00005641 2012-12-11

Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Graft vs Host Disease, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡